Skip to content
Saturday, July 25, 2026
  • Terms and Conditions
  • Affiliate Disclosure
  • Editorial Policy
  • Fact Checking Policy
7 Globe News

7 Globe News

Random posts
  • Home
  • Most Read
  • Top Stories
  • World
  • India
  • Entertainment
  • Web Stories
  • Sports
  • Business
  • Finance
  • Personal Finance
  • Market
  • Mutual Fund
  • Tech
  • Environment
  • Auto
  • Education
  • Life & Style
  • Science
  • Terms and Conditions
  • Affiliate Disclosure
  • Editorial Policy
  • Fact Checking Policy
7 Globe News

7 Globe News

Random posts
  • Home
  • Most Read
  • Top Stories
  • World
  • India
  • Entertainment
  • Web Stories
  • Sports
  • Business
  • Finance
  • Personal Finance
  • Market
  • Mutual Fund
  • Tech
  • Environment
  • Auto
  • Education
  • Life & Style
  • Science
  • Home
  • Market
  • Bata India share price in focus: Brokerages turn bearish on Bata India after Q4 miss; see up to 24% downside – Check latest target price
  • Market

Bata India share price in focus: Brokerages turn bearish on Bata India after Q4 miss; see up to 24% downside – Check latest target price

7 Globe News2 months ago2 months ago01 mins
Bata India share price in focus: Brokerages turn bearish on Bata India after Q4 miss; see up to 24% downside - Check latest target price


Bata India share price in focus: Brokerages turn bearish on Bata India after Q4 miss; see up to 24% downside – Check latest target price



Source link

Post navigation

Previous: PNB says all Mastercard services in Russia remain suspended
Next: Michael Jackson The Verdict review: A reality check for fans after $850-mn biopic whitewash | Web-series News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Oracle Financial Services shares jump 4% after profit, operating income doubles in Q1

Oracle Financial Services shares jump 4% after profit, operating income doubles in Q1

7 Globe News4 minutes ago4 minutes ago 0
Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

7 Globe News24 minutes ago24 minutes ago 0
WhiteOak’s Prashant Khemka stays bullish on healthcare, small NBFCs and manufacturing-led growth

AU Small Finance Bank Q1 net profit rises 37%, NII up 31.8%

7 Globe News44 minutes ago44 minutes ago 0
‘FII flows likely to remain volatile’ - Here's what Bajaj Broking’s Pabitro Mukherjee said on equity markets, crude oil prices

‘FII flows likely to remain volatile’ – Here's what Bajaj Broking’s Pabitro Mukherjee said on equity markets, crude oil prices

7 Globe News1 hour ago1 hour ago 0

Trending News

Entertainment
Meghan Markle’s new photos cause social media stir and backlash: ‘How disrespectful, exploitative and gross’ |

Recent Posts

  • Meghan Markle’s new photos cause social media stir and backlash: ‘How disrespectful, exploitative and gross’ |
  • How IVF changed millions of lives: The story behind World IVF Day
  • Oracle Financial Services shares jump 4% after profit, operating income doubles in Q1
  • Dharmendra Pradhan resigns as Union education minister amid massive student protests | India News
  • India’s Sri Lanka squad by Tuesday; BCCI review to put support staff under scanner | Cricket News

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy